The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Structure‐Guided Design and Synthesis of a Mitochondria‐Targeting Near‐Infrared Fluorophore with Multimodal Therapeutic Activities
Abstract
An urgent challenge for imaging‐guided disease‐targeted multimodal therapy is to develop the appropriate multifunctional agents to meet the requirements for potential applications. Here, a rigid cyclohexenyl substitution in the middle of a polymethine linker and two asymmetrical amphipathic N‐alkyl side chains to indocyanine green (ICG) (the only FDA‐approved NIR contrast agent) are introduced, and a new analog, IR‐DBI, is developed with simultaneous cancer‐cell mitochondrial targeting, NIR imaging, and chemo‐/PDT/PTT/multimodal therapeutic activities. The asymmetrical and amphipathic structural modification renders IR‐DBI a close binding to albumin protein site II to form a drug–protein complex and primarily facilitates its preferential accumulation at tumor sites via the enhanced permeability and retention (EPR) effect. The released IR‐DBI dye is further actively taken up by cancer cells through organic‐anion‐transporting polypeptide transporters, and the lipophilic cationic property leads to its selective accumulation in the mitochondria of cancer cells. Finally, based on the high albumin‐binding affinity, IR‐DBI is modified into human serum albumin (HSA) via self‐assembly to produce a nanosized complex, which exhibits significant improvement in the cancer targeting and multimodal cancer treatment with better biocompatibility. This finding may present a practicable strategy to develop small‐molecule‐based cancer theranostic agents for simultaneous cancer diagnostics and therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Mito‐Bomb: Targeting Mitochondria for Cancer Therapy
Guo, X., Yang, N., Ji, W., Zhang, H., Dong, X., Zhou, Z., Li, L., Shen, H., Yao, S. Q., & Huang, W. (2021) · Advanced Materials · doi:10.1002/adma.202007778 · Cited by 421
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 373
Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
Ni, K., Lan, G., Veroneau, S. S., Duan, X., Song, Y., & Lin, W. (2018) · Nature Communications · doi:10.1038/s41467-018-06655-7 · Cited by 329
Near Infrared (NIR) absorbing dyes as promising photosensitizer for photo dynamic therapy
Chinna Ayya Swamy, P., Sivaraman, G., Priyanka, R. N., Raja, S. O., Ponnuvel, K., Shanmugpriya, J., & Gulyani, A. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213233 · Cited by 304
Metadata
- Authors
- Tan, X., Luo, S., Long, L., Wang, Y., Wang, D., Fang, S., Ouyang, Q., Su, Y., Cheng, T., & Shi, C.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2017-10-05
- Volume
- 29
- Issue
- 43
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2762554530
- Cited by
- 212
- References
- 1
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structure‐Guided Design and Synthesis of a Mitochondria‐Targeting Near‐Infrared Fluorophore with Multimodal Therapeutic Activities. https://app.cochat.ai/papers/10.1002/adma.201704196
- The paper
- Tan, X., Luo, S., Long, L., Wang, Y., Wang, D., Fang, S., Ouyang, Q., Su, Y., Cheng, T., & Shi, C. (2017). Structure‐Guided Design and Synthesis of a Mitochondria‐Targeting Near‐Infrared Fluorophore with Multimodal Therapeutic Activities. Advanced Materials. https://doi.org/10.1002/adma.201704196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.